Leadership
Giulio F. Draetta, M.D., Ph.D.
Chief Scientific Officer
Sr. Vice President & Head, Therapeutics Discovery
Philip Jones, Ph.D.
Vice President, Therapeutics Discovery
Head of Drug Discovery
Jason Bock, Ph.D.
Vice President, Therapeutics Discovery
Head of Biologics Product Development
Platform Leadership
The Therapeutics Discovery division supports four research platforms.
Institute for Applied Cancer Science (IACS)
-
Philip Jones, Ph.D.
Head of Drug Discovery
Oncology Research for Biologics and Immunotherapy Translation (ORBIT)
-
Dongxing Zha, Ph.D.
Institute Head
Neurodegeneration Consortium (NDC)
-
Jim Ray, Ph.D.
Head, Neurodegeneration Research